Back to substances
Deutsch|English
Translated automatically – community improvements welcome.
NOCAS_1016274
(6aR,9R)-4-butanoyl-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide, known as 1B-LSD, is a semi-synthetic lysergamide with psychedelic properties. It primarily acts as an agonist at the 5-HT2A receptor, thereby influencing perception and consciousness. The substance exhibits a mechanism similar to LSD, yet with its own pharmacological profiles.
Psychedelic
Mechanism of Action
- 5-HT2A-Agonist
- Partieller Dopaminagonist
Names / Identifiers
IUPAC: (6aR,9R)-4-butanoyl-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
Y6JQX3L6LP
2349376-12-9
N1-Butyryl-lysergic acid diethylamide
DTXSID801016274
Ergoline-8-carboxamide, 9,10-didehydro-N,N-diethyl-6-methyl-1-(1-oxobutyl)-, (8beta)-
ERGOLINE-8-CARBOXAMIDE, 9,10-DIDEHYDRO-N,N-DIETHYL-6-METHYL-1-(1-OXOBUTYL)-, (8.BETA.)-
RefChem:79592
DTXCID501474421
NOCAS_1016274
UNII-Y6JQX3L6LP
Mechanism of Action
1B-LSD acts primarily as an agonist at the 5-HT2A receptor, which is implicated in its psychedelic effects.
Entdecken
Ähnliche Substanzen
Basierend auf Substanzklasse, Rezeptoren, Wirkmechanismen und Wirkprofil.